Abbas Gholipour Shilabin

Title: Abbas Gholipour Shilabin: Innovator in Cannabinoid Research

Introduction

Abbas Gholipour Shilabin is a notable inventor based in Johnson City, TN (US). He has made significant contributions to the field of cannabinoid research, particularly in the development of compounds that have potential therapeutic applications. His work focuses on addressing visceral pain management and neurodegenerative disorders.

Latest Patents

Shilabin holds a patent for an orally bioavailable, brain-penetrant compound with selectivity for the cannabinoid type 2 receptor. This compound has potential use in managing visceral pain and treating neurodegenerative disorders. The patent details compounds of Formula I, methods of making these compounds, pharmaceutical compositions, and methods for treating pain and neurological disorders. The compounds are designed to selectively bind to the CB2 receptor, penetrate the blood-brain barrier, and possess a half-life of 20 hours or greater.

Career Highlights

Throughout his career, Shilabin has focused on innovative approaches to cannabinoid research. His work has the potential to impact the treatment of various medical conditions, showcasing his commitment to advancing medical science. With a patent count of 1 patent, he continues to explore new avenues in his field.

Collaborations

Shilabin has collaborated with notable colleagues, including Larry Walker and Meirambek Ospanov. These partnerships have contributed to the development and refinement of his research projects.

Conclusion

Abbas Gholipour Shilabin is a pioneering inventor whose work in cannabinoid research holds promise for future medical advancements. His innovative compounds may lead to significant improvements in pain management and the treatment of neurodegenerative disorders.